# 1. Purpose

The purpose of this assessment is to evaluate cybersecurity considerations associated with the legacy connected infusion-pump environment and identify security risks, dependencies, visibility gaps, and areas requiring further investigation.

The assessment focuses on device lifecycle and support status, security updates, network connectivity, potential vulnerability exposure, access and monitoring dependencies, and the relationship between cybersecurity considerations and clinical operations.

This assessment supports **current-state discovery, risk and gap analysis, and decision readiness**. It does not define future-state security architecture, select remediation approaches, or implement security controls.

# 2. Cybersecurity Assessment Approach

The assessment follows this general sequence:

**Device & Lifecycle → Security Updates → Vulnerability Exposure → Connectivity
→ Security Dependencies → Clinical Criticality → Risk & Gap Assessment →
Areas for Further Investigation**

This approach recognizes that cybersecurity risk must be evaluated in the context of both the technical environment and the clinical role of the device.

The assessment documents available evidence, stakeholder-reported information, assumptions, unknowns, and areas requiring further investigation. It does not determine or implement specific remediation actions.

# 3. Device Lifecycle and Security Support

For each selected infusion pump, the assessment should consider:

- Device model and lifecycle status
- Current vendor support status
- Availability of security patches or firmware updates
- Availability of vendor-supported upgrades
- Known technical limitations
- Dependencies on vendor support services
- Whether the device remains within an appropriate support lifecycle

Unsupported or outdated devices should be identified as cybersecurity and lifecycle considerations requiring further investigation.

The assessment should document available evidence regarding device support, security updates, technical limitations, and vendor dependencies. It should not assume that an unsupported or outdated device requires a specific response. Potential impacts, dependencies, and unresolved questions should be documented for consideration in subsequent decision-making.

# 4. Network Connectivity and Security Exposure

The assessment should determine:

- Whether the infusion pump is currently network-connected
- Whether the device is technically capable of network connectivity
- What network infrastructure supports the connection
- What systems or integration components the device communicates with
- How information moves through the connected environment
- What security boundaries exist around the device
- What network monitoring or visibility is available
- What connectivity dependencies or security considerations require further investigation

The current-state architecture identifies network infrastructure, the infusion integration gateway, enterprise interface engine, EHR/supporting clinical systems, network monitoring, interface monitoring, and identity/access management as components or dependencies within the environment.

# 5. Vulnerability and Risk Considerations

The assessment should identify and document:

- Known or suspected vulnerability exposure
- Whether security updates are available
- Potential impact of identified vulnerabilities
- Device connectivity and exposure
- Clinical criticality
- Operational consequences if connectivity or device access must be restricted
- Dependencies that could affect risk assessment
- Gaps in current security visibility or control

The assessment should distinguish between identifying a vulnerability and determining its actual risk to HIHS. Risk should be considered in the context of device connectivity, clinical criticality, operational dependencies, existing security controls, and available evidence.

Unresolved questions, evidence gaps, and areas requiring additional cybersecurity investigation should be documented as part of the current-state findings.

# 6. Access, Monitoring, and Security Dependencies

The assessment should examine applicable dependencies involving:

- Identity and access management
- Network monitoring
- Interface monitoring
- Device and asset records
- Vendor support
- Network infrastructure
- Integration components

The current-state architecture identifies Identity and Access Management as supporting authentication and access controls for applicable systems, while Network Monitoring and Interface Monitoring provide visibility into network connectivity and interface operational status.

The assessment should identify gaps or uncertainties involving visibility, ownership, monitoring, or access controls and document areas requiring further investigation.

# 7. Clinical and Operational Impact

Cybersecurity considerations cannot be evaluated independently from clinical operations.

If a device has connectivity, access, or security concerns, HIHS should evaluate the potential effects on:

- Clinical workflow
- Required information flows
- Device availability
- Connected-system dependencies
- Operational continuity
- Manual workarounds
- Clinical and operational dependencies that require further investigation

The assessment should document how cybersecurity conditions may affect clinical functionality, information exchange, workflow dependencies, and operational continuity. It should also identify evidence gaps, assumptions, and unresolved questions requiring further investigation.

# 8. Cybersecurity Concerns Requiring Further Investigation

Where a cybersecurity concern is identified, the assessment should document the condition, available evidence, affected devices or systems, relevant dependencies, and potential clinical or operational impact.

Areas for further investigation may include:

- Device or firmware support status
- Availability of vendor security updates
- Network connectivity and exposure
- Access and authentication dependencies
- Monitoring and visibility
- Interface and integration dependencies
- Existing security controls
- Vendor support dependencies
- Clinical and operational dependencies
- Evidence gaps or unresolved technical questions

The assessment does not select, design, or implement remediation measures. Specific response options, security controls, or modernization approaches may be evaluated in a subsequent phase based on the documented current-state findings.

# 9. Risk and Gap Prioritization

Cybersecurity findings should be documented and prioritized based on factors such as:

- Severity or potential impact of the identified issue
- Device clinical criticality
- Network connectivity and exposure
- Vendor/lifecycle status
- Availability of security updates
- Dependency on connected systems
- Existing security controls and visibility
- Potential impact on clinical continuity

# 10. Assessment Outcome

The Cybersecurity Assessment provides HIHS with a structured view of cybersecurity considerations affecting the legacy connected infusion-pump environment.

The assessment supports identification of:

- Devices requiring additional cybersecurity review
- Lifecycle and security-support concerns
- Connectivity-related exposure
- Security dependencies and visibility gaps
- Risks requiring prioritization
- Cybersecurity considerations that may affect clinical continuity
- Evidence gaps, assumptions, and unresolved questions requiring further investigation

The assessment provides a foundation for consolidating technical, clinical, operational, and cybersecurity observations into the **Current-State Findings** and supporting decision-readiness for subsequent phases of analysis.
The resulting cybersecurity risks and gaps will be consolidated into **Section 07 — Current-State Findings** and used to support decision-readiness and identification of areas requiring further investigation.

